This information reflects FDA’s current analysis of available data concerning these drugs.
ROCKVILLE, Md., Jan. 8, 2009--On January 25, 2008, FDA announced that it would be reviewing data from the ENHANCE trial (Effect of Combination Ezetimibe...
PHILADELPHIA, Jan. 7, 2009 – The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to...
BERKELEY, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Jan 8, 2009 - Plexxikon Inc. and Roche (SWX:ROG), today announced that they have entered into an agreement to develop and commercialize a second novel kinase inhibitor, PLX5568. The main...
WorstPills.org Lists 56 Medications That May Cause Dangerous Interactions or Alter the Effectiveness of Erectile Dysfunction Drugs
WASHINGTON, Jan. 6, 2009 – People who take three well-known erectile dysfunction medications should be extremely...
ARLINGTON, Va., January 06, 2009/PRNewswire-USNewswire/ -- HealthCentral (www.HealthCentral.com), the leading collection of online condition-specific consumer health and wellness experiences, today announced that it was identified as one of the top...
USC dentist links Fosomax-type drugs to jaw necrosis
LOS ANGELES, Jan 2, 2009-Researchers at the University Of Southern California, School Of Dentistry release results of clinical data that links oral bisphosphonates to increased jaw necrosis. The...
ROCKVILLE, Md., Dec. 31, 2008-Celgene has issued a Dear Healthcare Professional letter describing a controlled clinical study suggesting that Innohep may increase the risk for death, compared to unfractionated heparin when used to treat elderly...
RARITAN, N.J., December 31, 2008 /PRNewswire/ -- PriCara(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., said today that one lot of 50 microgram/hour (mcg/hr) DURAGESIC(R) (fentanyl transdermal system) CII patches sold by PriCara in the...
TORONTO--(BUSINESS WIRE)--Dec 30, 2008 - Biovail Corporation today announced a voluntary recall of certain lots of Ultram® ER (extended-release tramadol hydrochloride) 100mg tablets from pharmacies and wholesalers. Biovail is taking this action...
CHICAGO, Dec. 23, 2008—A survey suggests that nearly half of older adults in the U.S. use prescription and over-the-counter medications together, and that about 4 percent of older adults are potentially at risk of an adverse drug reaction...
LONDON, December 23, 2008 /PRNewswire-FirstCall/ -- GlaxoSmithKline (GSK) and Cytokinetics, Incorporated announced today that GSK has informed Cytokinetics that it will not exercise its option to license ispinesib or SB-743921 as...
ROCKVILLE, Md., Dec. 24, 2008--The FDA posted on its web site yesterday a letter it sent to Abbott Laboratories about a review of an American Academy of Dermatology (AAD) Post Meeting News Ad for Humira. According to the FDA, "This AAD...
Packaged lot #: 90219 Expiration Date: 3/2010 Manufacture Date: 3/6/08
ST. LOUIS, December 23, 2008 /PRNewswire/ -- ETHEX Corporation announced today that it has voluntarily recalled to the consumer level, a single production lot of Hydromorphone...
Initiates Nationwide Single Lot Recall of Hydromorphone HCl (2mg) Due to Oversized Tablet
ST. LOUIS, December 23, 2008 /PRNewswire-FirstCall/ -- KV Pharmaceutical has advised the U.S. Food and Drug Administration (FDA) that, effective midnight Dec....
Researchers Use IMS Information to Assess Sales Trends, Healthcare System Opportunities and Risks
NORWALK, Conn.--(BUSINESS WIRE)--Dec. 23, 2008--A major reduction in real prescription drug spending growth has created a "turning point" in healthcare...
All Rights Revert to Dynavax
BERKELEY, Calif.--(BUSINESS WIRE)--Dec 19, 2008 - Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the termination of a global license and development collaboration agreement with Merck & Co., Inc. for...
ROCKVILLE, Md., Dec. 17, 2008-The U.S. Food and Drug Administration recommended today that manufacturers developing new drugs and biologics for type 2 diabetes provide evidence that the therapy will not increase the risk of such cardiovascular...
COPENHAGEN, Dec. 17, 2008--H. Lundbeck A/S has initiated a clinical phase III programme with desmoteplase in the treatment of acute ischemic stroke. The programme consists of two phase III clinical placebo-controlled trials, each enrolling...
ROCKVILLE, Md., Dec. 16, 2008-The U.S. Food and Drug Administration today announced it will require the manufacturers of antiepileptic drugs to add to these products' prescribing information, or labeling, a warning that their use increases risk of...
ROCKVILLE, Md., Dec. 16, 2008-A study released today by the U.S. Food and Drug Administration found that the printed consumer medication information (CMI) voluntarily provided with new prescriptions by retail pharmacies does not consistently provide...
More...